Cbl-b-IN-13

• UNSPSC Description:

  Cbl-b-IN-13 (Example 520) is a Cbl-b inhibitor with an IC50 of [1].

• Target Antigen:

  E1/E2/E3 Enzyme

• Type:

  Reference compound

• Related Pathways:

  Metabolic Enzyme/Protease

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/cbl-b-in-13.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C1C2=CC(CN3CCC4(CC4)C3)=CC(C(F)(F)F)=C2CN1C5=CC=CC(C6(CC7=NN=CN7C)COC6)=C5

• Molecular Weight:

  537.58

• References & Citations:

  [1]Paul A. Barsanti, et al. Inhibitors of cbl-b and methods of use thereof. Patent WO2019148005A1.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2368841-85-2